A Phase 1 Bioequivalence Study to Assess the Pharmacokinetics, Safety and Tolerability of Guselkumab After a Single‐Dose Administration via Two Subcutaneous Injection Devices in Healthy Volunteers. - Jeong, Angela; Weisel, Kathleen; Dimitrova, Dessislava; Donnelly, Brianna; Wang, Daniel; Vermeulen, An; Xu, Zhenhua (Clinical Pharmacology in Drug Development, 2026)